🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Register Study: Implementation of Pharyngeal Electrostimulation Therapy for the Treatment of Acute Neurogenic Dysphagia

Recruitingn/aAges 18 Years - anyAllKarl Landsteiner University of Health Sciences
NCT05190718 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Neurogenic dysphagia occurs with disruption of neurological systems or processes involved in the execution of coordinated and safe swallowing. It is common in patients with neurological diseases, in particular in patients treated in Intensive Care Units (ICU) who are intubated (up to 62%) and / or tracheotomised (up to 83%). Dysphagia is one of the most common and most dangerous symptoms of many neurological diseases. In addition, neurogenic dysphagia can have a significant impact on quality of life, medication efficacy, and malnutrition. Dysphagia is currently treated conservatively on evidence-based exercises, individually adapted to each patient. In the recent years pharyngeal electrostimulation has been established and shown a positive impact on outcome. In fact, this type of therapy has not only become an addition to the existing therapy, but an important alternative for patients d

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Neurogenic dysphagia * Ischaemic and haemorrhagic strokes * Infra- as well as supra-tentorial * Polyradiculitis * Parkinson's disease * Multiple sclerosis * Dementia * Traumatic brain injury * Post Covid-19 pat. * patients over the age of 18. Exclusion Criteria: * Contraindication to nasogastric tube, * Unstable cardiac or respiratory condition that does not allow the insertion of the Nasogastric tube * Pacemakers * Implanted defibrillators (ICD) * Pregnant * Breastfeeding women (Caution: interfering signals may be visible in ECGs, \& EEGs with continuous recording).
💊

What it tests

  • Pharyngeal electrostimulation
📍

Where

1 site
University Clinic Tulln
Tulln, Austria
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy